English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105672 (86%)
Visitors : 14936954      Online Users : 296
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/112027

    Title: Benzodiazepines Associated With Acute Respiratory Failure in Patients With Obstructive Sleep Apnea.
    Authors: Sheng-Huei, W;Wang, Sheng-Huei;Che, Wei-Shan;Chen, Wei-Shan;Tang, Shih-En;Tang, Shih-En;Lin, Hung-Che;Lin, Hung-Che;Pe, Chung-Kan;Peng, Chung-Kan;Chu, Hsuan-Te;Chu, Hsuan-Te;高嘉鴻;Kao, Chia-Hung
    Contributors: 生物資訊與醫學工程學系
    Date: 2019-01
    Issue Date: 2019-09-10 14:59:33 (UTC+8)
    Abstract: Aims: Obstructive sleep apnea (OSA) and insomnia commonly coexist; hypnotics are broadly prescribed for insomnia therapy. However, the safety of hypnotics use in OSA patients is unclear. We conducted a retrospective case-control study to investigate the risk of adverse respiratory events in hypnotics-using OSA patients.

    Methods: We obtained data from the Taiwan National Health Insurance Database from 1996 to 2013. The case group included 216 OSA patients with newly diagnosed adverse respiratory events, including pneumonia and acute respiratory failure. The control group included OSA patients without adverse respiratory events, which was randomly frequency-matched to the case group at a 1:1 ratio according to age, gender, and index year. Hypnotics exposure included benzodiazepines (BZD) and non-benzodiazepines (non-BZD). A recent user was defined as a patient who had taken hypnotics for 1–30 days, while a long-term user was one who had taken hypnotics for 31–365 days.

    Results: Multivariable adjusted analysis showed recent BZD use is an independent risk for adverse respiratory events (OR = 2.70; 95% CI = 1.15–6.33; P < 0.001). Subgroup analysis showed both recent and long-term BZD use increased the risk of acute respiratory failure compared to never BZD use (OR = 28.6; 95% CI = 5.24–156; P < 0.001, OR = 10.1; 95% CI = 1.51–67.7; P < 0.05, respectively). Neither BZD nor non-BZD use increased the risk of pneumonia in OSA patients.

    Conclusion: BZD use might increase the risk of acute respiratory failure in OSA patients.

    Keywords: benzodiazepines, hypnotics, obstructive sleep apnea, acute respiratory failure, pneumonia
    Relation: Frontiers in Pharmacology
    Appears in Collections:[生物資訊與醫學工程學系 ] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback